Waters Corporation (WAT) Gross Margin: 55.02%
Is Waters Corporation’s gross margin high or low?
Waters Corporation's gross margin of 55.02% is in line with its 5-year average of 58.45%, near the low end of its 5-year range (57.44%–59.57%).
The gross margin for Waters Corporation (WAT) is 55.02% as of Wednesday, June 10, 2026. It is below its 12-month average by 6.11% (58.60%).
WAT Gross Margin Chart
WAT Average Gross Margin Chart
WAT Current vs Average Gross Margin Chart
WAT Gross Margin Metrics
GROSS MARGIN
55.02%
GROSS MARGIN AVG TTM
58.60%
GROSS MARGIN AVG 3Y
58.69%
GROSS MARGIN AVG 5Y
58.45%
GROSS MARGIN AVG 10Y
58.57%
GROSS MARGIN AVG 15Y
58.90%
GROSS MARGIN AVG 20Y
58.80%
CURRENT VS TTM AVG
-6.11%
CURRENT VS 3Y AVG
-6.26%
CURRENT VS 5Y AVG
-5.87%
CURRENT VS 10Y AVG
-6.06%
CURRENT VS 15Y AVG
-6.59%
CURRENT VS 20Y AVG
-6.43%
WAT Competitors' Gross Margin
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | — | 55.02% | 58.60% | 58.69% | 58.45% |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 57.79% | 57.84% | 57.54% | 57.23% |
| BioNTech SE (BNTX) | $21.81B | 73.26% | 78.98% | 81.24% | 82.89% |
| Veeva Systems Inc. (VEEV) | $26.73B | 74.95% | 75.03% | 73.28% | 73.00% |
| Biogen Inc. (BIIB) | $29.00B | 69.77% | 73.30% | 74.61% | 77.63% |
| DexCom, Inc. (DXCM) | $29.24B | 61.84% | 60.23% | 62.09% | 63.91% |
| Moderna, Inc. (MRNA) | $18.40B | -13.89% | 54.80% | 53.09% | 65.45% |
| IQVIA Holdings Inc. (IQV) | $30.60B | 26.11% | 30.59% | 32.75% | 33.07% |
| Hologic, Inc. (HOLX) | $16.97B | 52.82% | 58.14% | 57.33% | 59.28% |
| Centene Corporation (CNC) | $31.94B | 14.93% | 11.28% | 11.33% | 11.71% |
Gross Margin Analysis
Gross Margin
55.0%
(Revenue - COGS) / Revenue
Waters Corporation Gross Margin Formula & Definition
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Waters Corporation Gross Margin FAQ
- What is the gross margin for Waters Corporation (WAT)?
- The gross margin for WAT stock is 55.02%.
- Is Waters Corporation's gross margin high or low?
- Waters Corporation's gross margin of 55.02% is in line with its 5-year average of 58.45%, near the low end of its 5-year range (57.44%–59.57%).
- What is the TTM average gross margin for Waters Corporation (WAT)?
- The TTM average gross margin for WAT stock is 58.60%.
- What is the 3Y average gross margin for Waters Corporation (WAT)?
- The 3Y average gross margin for WAT stock is 58.69%.
- What is the 5Y average gross margin for Waters Corporation (WAT)?
- The 5Y average gross margin for WAT stock is 58.45%.
- What is the 10Y average gross margin for Waters Corporation (WAT)?
- The 10Y average gross margin for WAT stock is 58.57%.
- What is the 15Y average gross margin for Waters Corporation (WAT)?
- The 15Y average gross margin for WAT stock is 58.90%.
- What is the 20Y average gross margin for Waters Corporation (WAT)?
- The 20Y average gross margin for WAT stock is 58.80%.
Waters Corporation Gross Margin History
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 57.77% |
| 2024-12-31 | 59.43% |
| 2023-12-31 | 59.57% |
| 2022-12-31 | 58.00% |
| 2021-12-31 | 58.49% |
| 2020-12-31 | 57.44% |
| 2019-12-31 | 58.00% |
| 2018-12-31 | 58.98% |
| 2017-12-31 | 58.99% |
| 2016-12-31 | 58.87% |
| 2015-12-31 | 58.74% |
| 2014-12-31 | 58.53% |
| 2013-12-31 | 58.86% |
| 2012-12-31 | 59.99% |
| 2011-12-31 | 60.54% |
| 2010-12-31 | 60.25% |
| 2009-12-31 | 60.31% |
| 2008-12-31 | 58.02% |
| 2007-12-31 | 57.16% |
| 2006-12-31 | 58.12% |
| 2005-12-31 | 58.70% |
| 2004-12-31 | 58.82% |
| 2003-12-31 | 58.48% |
| 2002-12-31 | 58.04% |
| 2001-12-31 | 63.78% |
| 2000-12-31 | 66.56% |
| 1999-12-31 | 66.55% |
| 1998-12-31 | 65.51% |
| 1997-12-31 | 65.91% |
| 1996-12-31 | 65.84% |
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra